ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling

Zhang, Fan; Attarilar, Shokouh; Xie, Kegong; Han, Chao; Liang, Qingyang; Huang, Ke; Lan, Changgong; Wang, Chong; Yang, Chengliang; Wang, Liqiang; Mozafari, Masoud; Li, Kai*; Liu, Jia*; Tang, Yujin*东莞理工学院; 南方医科大学; 上海交通大学
Molecular and Cellular Endocrinology2022-1-15DOI: 10.1016/j.mce.2021.111520
6被引6阅读
引用收藏
分享

摘要

Osteoporosis (OP) is characterized by decreased bone mineral density and impaired bone strength. Carfilzomib (CFZ) is a new-generation proteasome inhibitor and has been found to affect bone metabolism. However, the effect and mechanism of CFZ on OP has not been investigated systematically. In this study, we found that protein levels of proteasome activator subunit 1/2 (PSME1/2) increased in OP, and accumulated mostly in osteoblasts and osteoclasts. Treatment with PSME1/2 recombinant protein inhibited osteogenesis and promoted osteoclast formation in vitro. Also, PSME1/2 inhibited the expression of beta-catenin protein, resulting in limitation of Wnt/ beta-catenin signaling. CFZ inhibited PSME1 and PSME2 proteasome activities and increased beta-catenin protein level, resulting in the translocation of beta-catenin to the nucleus and activation of canonical Wnt/beta-catenin signaling, further promoting osteogenesis and inhibiting osteoclastic differentiation. In vivo, we conducted ovariectomy (OVX) to create a model of OVX-induced postmenopausal OP in mice. When analyzed by micro-CT scanning, enhancement of bone mineral density, bone volume, trabecular number, and thickness was seen in the CFZtreated mice. Also, we noticed increased osteogenesis and decreased osteoclastogenesis, diminished expression of PSME1 and PSME2 and activated Wnt/beta-catenin signaling in bone sections from OP mice treated with CFZ. Overall, our data indicated that PSME1/2 may serve as new targets for the treatment of OP, and targeting PSME1/2 with CFZ provides a candidate therapeutic molecule for postmenopausal OP.

学科与关键词

关键词
OsteoporosisCarfilzomibProteasome inhibitorBone metabolismbeta-catenin signaling
相关
加载中…
  • Targeting Filamin A alleviates ovariectomy-induced bone loss in mice via the WNT/β-catenin signaling pathway
    Yang, Changsheng; Yang, Panpan; Liu, Peilin; Wang, Hong; Ke, Ee*; Li, Kai*; Yan, Huibo*Cellular Signalling, 2022, 90: 110191.被引 9
  • Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway
    Yuan, Shi-Guo; Hu, Hong-Ling; Wang, Xin-Jia; Yang, Jin-Cheng; Zhou, Rong-Ping; Bai, Xiao-Chun*; Lai, Ping-Lin*Orthopaedic Surgery, 2022, 14(6): 1203-1216.被引 4
  • 3D Printing of Tricalcium Phosphate/Poly Lactic-co-glycolic Acid. Scaffolds Loaded with Carfilzomib for Treating Critical-sized Rabbit Radial Bone Defects
    Li, Ye; Xie, Kegong; Wang, Chong; Yang, Chengliang; Huang, Ke; Li, Feng; Zheng, Chuanchuan; Chen, Jian; Dong, Shujun; Deng, Guangfeng; Huang, Gege; Lu, Qiaoyan; Liu, Jia*; Li, Kai*; Tang, Yujin*; Wang, LiqiangInternational Journal of Bioprinting, 2021, 7(4): 99-111.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular and Cellular Endocrinology
发表日期
2022-01-15
卷期
第 540 卷
页码
111520
DOI
10.1016/j.mce.2021.111520
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Guangxi Science and Technology Program [2018GXNSFAA294116, 2018GXNSFAA138074, 2018GXNSAA294091, 198]; Guangxi key R D Project [Guike AB18050008]; High-level Innovation team and Outstanding Scholars Program of Colleges and Universities in Guangxi: innovative team of basic and Clinical Comprehensive Research on Bone and Joint degen-erative Diseases, Scientific Research Project of High-level talents in [R20196301]

作者

  • Z

    Zhang, Fan (第一作者)

    youjiang med univ nationalities · b

  • A

    Attarilar, Shokouh

    shanghai jiao tong univ

查看全部 14 位作者收起作者
  • X

    Xie, Kegong

    youjiang med univ nationalities · b

  • H

    Han, Chao

    b · youjiang med univ nationalities

  • L

    Liang, Qingyang

    youjiang med univ nationalities · b

  • H

    Huang, Ke

    youjiang med univ nationalities · b

  • L

    Lan, Changgong

    youjiang med univ nationalities · b

  • W

    Wang, Chong

    dongguan univ technol

  • Y

    Yang, Chengliang

    youjiang med univ nationalities · b

  • W

    Wang, Liqiang

    shanghai jiao tong univ

  • M

    Mozafari, Masoud

  • L

    Li, Kai (通讯)

    southern med univ

  • L

    Liu, Jia (通讯)

    2 · youjiang med univ nationalities · b

  • T

    Tang, Yujin (通讯)

    2 · youjiang med univ nationalities · b

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417